Clinical Trial

Median Nerve Cross-Sectional Area and Body Weight in Carpal Tunnel Syndrome

Study acronym: CTS-US-WEIGHT
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 2, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the diagnostic accuracy of ultrasonographic measurements of the median nerve in patients with Carpal Tunnel Syndrome (CTS). While ultrasound is a common diagnostic tool, various physical factors can influence its results. The researchers will investigate how a patient's absolute body weight and Body Mass Index (BMI) affect the size of the median nerve cross-sectional area across different stages of disease severity. The goal is to determine if absolute body weight plays a 'masking' role that could lead to more precise diagnostic interpretations in clinical practice.
Trial Details
NCT Number NCT07508397
Lead Sponsor Kayseri City Hospital
Conditions Carpal Tunnel Syndrome, Entrapment Neuropathies, Median Nerve Compression
Enrollment 120 participants
Start Date 2026-04-01
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-02